NEW YORK (GenomeWeb News) – BG Medicine said today that the Nasdaq Listing Qualifications Panel has granted its request to transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market.

BG requested the transfer, which is effective at open of business today, after failing to meet the $50 million market value of listed securities requirement for listing on the Global Market. The Capital Market requires a company maintain $35 million market value or $2.5 million in stockholders equity.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.